A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, ASCENDING-DOSE, SAFETY STUDY OF CC-220 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：1
|
作者：
Werth, V. P. [1 ]
Furie, R. [2 ]
Korish, S. [3 ]
Weiswasser, M. [3 ]
Azaryan, A. [3 ]
Schafer, P. H. [3 ]
Delev, N. [3 ]
Choi, S. [3 ]
Hough, D. [3 ]
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] Northwell Hlth, Great Neck, NY USA
[3] Celgene Corp, Summit, NJ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3546
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0255
引用
收藏
页码：870 / 871
页数：2
相关论文
共 50 条
  • [21] Baricitinib in Patients with Systemic Lupus Erythematosus: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Wallace, Daniel J.
    Furie, Richard
    Tanaka, Yoshiya
    Kalunian, Kenneth C.
    Mosca, Marta
    Petri, Michelle
    Dorner, Thomas
    Cardiel, Mario H.
    Bruce, Ian N.
    Gomez, Elisa
    DeLozier, Amy M.
    Janes, Jonathan
    Linnik, Matthew D.
    de Bono, Stephanie
    Silk, Maria E.
    Hoffman, Robert W.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [22] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
    Haiyan Li
    Yudong Wei
    Zhenhua Yang
    Shuang Zhang
    Xiuxiu Xu
    Mengmeng Shuai
    Olivier Vitse
    Yiwen Wu
    Marie T. Baccara-Dinet
    Yi Zhang
    Jianyong Li
    American Journal of Cardiovascular Drugs, 2020, 20 : 489 - 503
  • [23] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
    Li, Haiyan
    Wei, Yudong
    Yang, Zhenhua
    Zhang, Shuang
    Xu, Xiuxiu
    Shuai, Mengmeng
    Vitse, Olivier
    Wu, Yiwen
    Baccara-Dinet, Marie T.
    Zhang, Yi
    Li, Jianyong
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 489 - 503
  • [24] Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus Results of a phase I, placebo-controlled, double-blind, dose-escalation study
    McBride, Jacqueline M.
    Jiang, Jenny
    Abbas, Alexander R.
    Morimoto, Alyssa
    Li, Jing
    Maciuca, Romeo
    Townsend, Michael
    Wallace, Daniel J.
    Kennedy, William P.
    Drappa, Jorn
    ARTHRITIS AND RHEUMATISM, 2012, 64 (11): : 3666 - 3676
  • [25] A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus
    van Vollenhoven, RF
    Park, JL
    Genovese, MC
    West, JP
    McGuire, JL
    LUPUS, 1999, 8 (03) : 181 - 187
  • [26] Steroid-Sparing Effects of Methotrexate in Systemic Lupus Erythematosus: A Double-Blind, Randomized, Placebo-Controlled Trial
    Fortin, Paul R.
    Abrahamowicz, Michal
    Ferland, Diane
    Lacaille, Diane
    Smith, C. Douglas
    Zummer, Michel
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12): : 1796 - 1804
  • [27] Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus - A double-blind, randomized, placebo-controlled trial
    Petri, MA
    Lahita, RG
    van Vollenhoven, RF
    Merrill, JT
    Schiff, M
    Ginzler, EM
    Strand, V
    Kunz, A
    Gorelick, KJ
    Schwartz, KE
    ARTHRITIS AND RHEUMATISM, 2002, 46 (07): : 1820 - 1829
  • [28] A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers
    Wong, YN
    Simcoe, D
    Hartman, LN
    Laughton, WB
    King, SP
    McCormick, GC
    Grebow, PE
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (01): : 30 - 40
  • [29] Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial
    Hayashi, A. P.
    Solis, M. Y.
    Sapienza, M. T.
    Otaduy, M. C. G.
    Pinto, A. L. de Sa
    Silva, C. A.
    Sallum, A. M. E.
    Pereira, R. M. R.
    Gualano, B.
    LUPUS, 2014, 23 (14) : 1500 - 1511
  • [30] A randomized, double-blind placebo-controlled study of the safety of apadenoson in subjects with mild or moderate asthma
    Williams, S. P.
    Mcardle, J. R.
    Colice, G.
    Lankford, A.
    Kajdasz, D. K.
    Reed, C. R.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A95 - A96
12345